Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized,double-blind,placebo-controlled trial

Abstract

Objective:

Type 2 diabetes in the elderly is an important and insufficiently studied public health problem. This study evaluated sitagliptin monotherapy in patients with type 2 diabetes aged ≥65 years.